Market Cap 2.15B
Revenue (ttm) 55.23M
Net Income (ttm) -164.08M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -297.08%
Debt to Equity Ratio 0.00
Volume 6,152,200
Avg Vol 1,195,268
Day's Range N/A - N/A
Shares Out 33.79M
Stochastic %K 51%
Beta 1.14
Analysts Strong Sell
Price Target $144.00

Company Profile

Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in the field of immunotherapy in the United States and internationally. It develops rezpegaldesleukin, which is in Phase 2b to treat underlying immune system imbalance in people with autoimmune disorders and inflammatory diseases; NKTR-0165 to treat ulcerative colitis, vitiligo, and multiple sclerosis; NKTR-0166 to treat autoimmune disease; NKTR-422 to treat fibrotic diseases; and NKTR-255 to treat...

Industry: Biotechnology
Sector: Healthcare
Phone: 415 482 5300
Fax: 415 339 5300
Address:
455 Mission Bay Boulevard South, San Francisco, United States
BK217
BK217 Jun. 27 at 8:04 AM
$NKTR someone over on the twitter made a great point: where did that 5m shares of supply come from? That’s like 16% of the float and the stock barely moved. Bizarre
0 · Reply
Nktrlly
Nktrlly Jun. 26 at 10:22 PM
$NKTR and of course nktr officially joins the Russell 2000 effective close of trading today
1 · Reply
BK217
BK217 Jun. 26 at 9:38 AM
$NKTR there’s a lot of increasing interest in my shart
1 · Reply
paleogos
paleogos Jun. 25 at 5:18 PM
$NKTR the next $SGMO
1 · Reply
george4it
george4it Jun. 25 at 5:17 PM
$NKTR Yes, added another 1000 shares below 63.
0 · Reply
Baldchinese
Baldchinese Jun. 25 at 3:34 PM
$NKTR has to be one of the worst bio stocks out there. Red on a big green day like this. Sad
5 · Reply
george4it
george4it Jun. 24 at 11:29 PM
$NKTR I’m not buying the notion that it’s heading lower. But I’m ready with fresh capital to add a lot more. Bring it, again….
0 · Reply
HoHoHoHum
HoHoHoHum Jun. 22 at 7:09 PM
$AUPH big XBI move today and several commercial stage companies get valuation boost — other than AUPH, $RIGL $ALKS $TGTX $NKTR to name a few!
1 · Reply
breakoutstock
breakoutstock Jun. 22 at 6:47 PM
$NKTR pretty obvious they turned down an offer from $ABBV thid is a far superior drug. 🚀
1 · Reply
BioRich
BioRich Jun. 22 at 4:47 PM
$NKTR $JMIA $NRXP Are today's additions. $NKTR Has always been a very attractive stock and prime BO target (especially on the heels of the $APGE BO). Retreating from $100 to $60 creates a massive buying opportunity...and unfortunately the potential that a $100 BO benefits current share purchasers and essentially penalizes those that bought around $100. We've seen it before, and it sucks. $JMIA Another BO target. Once a very hot runner that's pulled back over the past few months. I believe it's time it starts to get renewed attention and their already established groundwork in an emerging market (Africa) puts them in the clear line of sight of acquirers. $NRXP This thing is a PR machine and continues to appear to improve. Today's announcement of Extended Access Program (EAP) further supports confidence in their ketamine-free approach to depression and suicidal thoughts. $DFTX's data reveal today only helps $NRXP in my opinion. Follow/Subscribe for more suggestions and perspective.
1 · Reply
Latest News on NKTR
Nektar Therapeutics Transcript: AGM 2026

Jun 4, 2026, 5:00 PM EDT - 24 days ago

Nektar Therapeutics Transcript: AGM 2026


Nektar price target lowered to $80 from $95 at Wedbush

2026-05-11T17:15:19.000Z - 6 weeks ago

Nektar price target lowered to $80 from $95 at Wedbush


Nektar price target raised to $192 from $105 at Piper Sandler

2026-05-08T11:17:20.000Z - 7 weeks ago

Nektar price target raised to $192 from $105 at Piper Sandler


Nektar Therapeutics Earnings Call Transcript: Q1 2026

May 7, 2026, 5:00 PM EDT - 7 weeks ago

Nektar Therapeutics Earnings Call Transcript: Q1 2026


Nektar Therapeutics Earnings release: Q1 2026

May 7, 2026, 5:00 PM EDT - 7 weeks ago

Nektar Therapeutics Earnings release: Q1 2026


Nektar Therapeutics Quarterly report: Q1 2026

May 7, 2026, 5:00 PM EDT - 7 weeks ago

Nektar Therapeutics Quarterly report: Q1 2026


Nektar reports Q1 adjusted EPS ($1.82), consensus ($1.48)

2026-05-07T20:52:57.000Z - 7 weeks ago

Nektar reports Q1 adjusted EPS ($1.82), consensus ($1.48)


Nektar Therapeutics Proxy statement: Proxy filing

Apr 24, 2026, 8:00 AM EDT - 2 months ago

Nektar Therapeutics Proxy statement: Proxy filing


Nektar Therapeutics Proxy statement: Proxy filing

Apr 24, 2026, 8:00 AM EDT - 2 months ago

Nektar Therapeutics Proxy statement: Proxy filing


Nektar price target raised to $95 from $70 at Wedbush

2026-04-21T15:55:35.000Z - 2 months ago

Nektar price target raised to $95 from $70 at Wedbush


Nektar price target raised to $151 from $123 at Citi

2026-04-21T10:56:02.000Z - 2 months ago

Nektar price target raised to $151 from $123 at Citi


Nektar announces $250M common stock offering

2026-04-20T20:06:22.000Z - 2 months ago

Nektar announces $250M common stock offering


Nektar Therapeutics Announces Proposed Public Offering

Apr 20, 2026, 4:01 PM EDT - 2 months ago

Nektar Therapeutics Announces Proposed Public Offering


Nektar rises 28.2%

2026-04-20T16:07:46.000Z - 2 months ago

Nektar rises 28.2%


Nektar rises 19.4%

2026-04-20T15:12:00.000Z - 2 months ago

Nektar rises 19.4%


Nektar price target raised to $185 from $165 at H.C. Wainwright

2026-04-20T15:02:50.000Z - 2 months ago

Nektar price target raised to $185 from $165 at H.C. Wainwright


Nektar Therapeutics Transcript: Study update

Apr 20, 2026, 8:00 AM EDT - 2 months ago

Nektar Therapeutics Transcript: Study update


Nektar Therapeutics Press release: Study update

Apr 20, 2026, 8:00 AM EDT - 2 months ago

Nektar Therapeutics Press release: Study update


Nektar Therapeutics Slides: Study update

Apr 20, 2026, 8:00 AM EDT - 2 months ago

Nektar Therapeutics Slides: Study update


Nektar reports new results from Phase 2b REZOLVE-AA study

2026-04-20T11:49:42.000Z - 2 months ago

Nektar reports new results from Phase 2b REZOLVE-AA study


Nektar initiated with a Neutral at Wedbush

2026-03-24T11:15:28.000Z - 3 months ago

Nektar initiated with a Neutral at Wedbush


Nektar Therapeutics Earnings Call Transcript: Q4 2025

Mar 12, 2026, 5:00 PM EDT - 3 months ago

Nektar Therapeutics Earnings Call Transcript: Q4 2025


Nektar Therapeutics Annual report: Q4 2025

Mar 12, 2026, 5:00 PM EDT - 3 months ago

Nektar Therapeutics Annual report: Q4 2025


Nektar Therapeutics Earnings release: Q4 2025

Mar 12, 2026, 5:00 PM EDT - 3 months ago

Nektar Therapeutics Earnings release: Q4 2025


Can NKTR Stock Sustain Its 1,000% Rally?

Feb 13, 2026, 9:30 AM EST - 4 months ago

Can NKTR Stock Sustain Its 1,000% Rally?


Nektar Therapeutics Transcript: Study result

Feb 10, 2026, 8:00 AM EST - 4 months ago

Nektar Therapeutics Transcript: Study result


Nektar Therapeutics Press release: Study result

Feb 10, 2026, 8:00 AM EST - 4 months ago

Nektar Therapeutics Press release: Study result


Nektar Therapeutics Slides: Study result

Feb 10, 2026, 8:00 AM EST - 4 months ago

Nektar Therapeutics Slides: Study result


Nektar Therapeutics Transcript: Study Result

Dec 16, 2025, 8:00 AM EST - 6 months ago

Nektar Therapeutics Transcript: Study Result


Nektar Therapeutics Press release: Study Result

Dec 16, 2025, 8:00 AM EST - 6 months ago

Nektar Therapeutics Press release: Study Result


Nektar Therapeutics Slides: Study Result

Dec 16, 2025, 8:00 AM EST - 6 months ago

Nektar Therapeutics Slides: Study Result


Nektar Therapeutics Earnings Call Transcript: Q3 2025

Nov 6, 2025, 5:00 PM EST - 8 months ago

Nektar Therapeutics Earnings Call Transcript: Q3 2025


Nektar Therapeutics Quarterly report: Q3 2025

Nov 6, 2025, 5:00 PM EST - 8 months ago

Nektar Therapeutics Quarterly report: Q3 2025


Nektar Therapeutics Earnings release: Q3 2025

Nov 6, 2025, 5:00 PM EST - 8 months ago

Nektar Therapeutics Earnings release: Q3 2025


Nektar Therapeutics Earnings Call Transcript: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 11 months ago

Nektar Therapeutics Earnings Call Transcript: Q2 2025


Nektar Therapeutics Quarterly report: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 11 months ago

Nektar Therapeutics Quarterly report: Q2 2025


Nektar Therapeutics Earnings release: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 11 months ago

Nektar Therapeutics Earnings release: Q2 2025


Nektar Therapeutics Transcript: Study Update

Jun 24, 2025, 8:15 AM EDT - 1 year ago

Nektar Therapeutics Transcript: Study Update


Nektar Therapeutics Press release: Study Update

Jun 24, 2025, 8:15 AM EDT - 1 year ago

Nektar Therapeutics Press release: Study Update


Nektar Therapeutics Slides: Study Update

Jun 24, 2025, 8:15 AM EDT - 1 year ago

Nektar Therapeutics Slides: Study Update


BK217
BK217 Jun. 27 at 8:04 AM
$NKTR someone over on the twitter made a great point: where did that 5m shares of supply come from? That’s like 16% of the float and the stock barely moved. Bizarre
0 · Reply
Nktrlly
Nktrlly Jun. 26 at 10:22 PM
$NKTR and of course nktr officially joins the Russell 2000 effective close of trading today
1 · Reply
BK217
BK217 Jun. 26 at 9:38 AM
$NKTR there’s a lot of increasing interest in my shart
1 · Reply
paleogos
paleogos Jun. 25 at 5:18 PM
$NKTR the next $SGMO
1 · Reply
george4it
george4it Jun. 25 at 5:17 PM
$NKTR Yes, added another 1000 shares below 63.
0 · Reply
Baldchinese
Baldchinese Jun. 25 at 3:34 PM
$NKTR has to be one of the worst bio stocks out there. Red on a big green day like this. Sad
5 · Reply
george4it
george4it Jun. 24 at 11:29 PM
$NKTR I’m not buying the notion that it’s heading lower. But I’m ready with fresh capital to add a lot more. Bring it, again….
0 · Reply
HoHoHoHum
HoHoHoHum Jun. 22 at 7:09 PM
$AUPH big XBI move today and several commercial stage companies get valuation boost — other than AUPH, $RIGL $ALKS $TGTX $NKTR to name a few!
1 · Reply
breakoutstock
breakoutstock Jun. 22 at 6:47 PM
$NKTR pretty obvious they turned down an offer from $ABBV thid is a far superior drug. 🚀
1 · Reply
BioRich
BioRich Jun. 22 at 4:47 PM
$NKTR $JMIA $NRXP Are today's additions. $NKTR Has always been a very attractive stock and prime BO target (especially on the heels of the $APGE BO). Retreating from $100 to $60 creates a massive buying opportunity...and unfortunately the potential that a $100 BO benefits current share purchasers and essentially penalizes those that bought around $100. We've seen it before, and it sucks. $JMIA Another BO target. Once a very hot runner that's pulled back over the past few months. I believe it's time it starts to get renewed attention and their already established groundwork in an emerging market (Africa) puts them in the clear line of sight of acquirers. $NRXP This thing is a PR machine and continues to appear to improve. Today's announcement of Extended Access Program (EAP) further supports confidence in their ketamine-free approach to depression and suicidal thoughts. $DFTX's data reveal today only helps $NRXP in my opinion. Follow/Subscribe for more suggestions and perspective.
1 · Reply
Baldchinese
Baldchinese Jun. 22 at 4:30 PM
$NKTR hopefully going north of 100
0 · Reply
BK217
BK217 Jun. 22 at 1:40 PM
$NKTR #crave
0 · Reply
Biohero
Biohero Jun. 22 at 1:36 PM
$NKTR 70$ EOW?
0 · Reply
BioRich
BioRich Jun. 22 at 12:59 PM
$NKTR Nice re-entry point. Seeing $NKTR gaining a lot of attention from the $APGE buyout. (I know many are trying to say that for all tickers, but $NKTR is the top dog for sympathy plays and/or next-up). Follow/Subscribe for more suggestions and perspective. Would love to hear yours too. That's how we find these gems and learn. Let's make some (more) money again. Cheers!
1 · Reply
nnnuuu
nnnuuu Jun. 22 at 11:27 AM
0 · Reply
Holschi
Holschi Jun. 21 at 3:46 PM
$NKTR $APGE Germany is trading at 54,98 € today ~ 63$ in Sunday Trading by Kang and Schwarz https://www.ls-tc.de/de/aktie/3810653
1 · Reply
Holschi
Holschi Jun. 21 at 11:43 AM
0 · Reply
calbucs
calbucs Jun. 20 at 9:46 PM
$NKTR Get ready !! BO in the Horizon !! If APGE is worth 11B then we will get premium dollars for NKTR . What’s your PT for BO ?
1 · Reply
Holschi
Holschi Jun. 20 at 11:21 AM
0 · Reply
Icarus81
Icarus81 Jun. 20 at 10:33 AM
$NKTR $CRVS MONDAY WE RIDE!! $APGE sympathy plays: https://www.reuters.com/business/healthcare-pharmaceuticals/abbvie-nears-11-billion-deal-apogee-therapeutics-ft-reports-2026-06-19/
0 · Reply
SannieVerraderlijk
SannieVerraderlijk Jun. 19 at 5:58 AM
$ABOS $CCCC $NKTR $RLMD $ SABS $ ZURA Some longs added to Russell 3000 yesterday
0 · Reply
Chicagomuni2pro
Chicagomuni2pro Jun. 19 at 3:41 AM
0 · Reply